These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1338740)

  • 21. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
    Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO
    J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
    Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between imidazoline/guanidinium receptive sites and monoamine oxidase A and B.
    Raddatz R; Lanier SM
    Neurochem Int; 1997 Jan; 30(1):109-17. PubMed ID: 9116581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The imidazoline-guanidinium receptor site, a target for some alpha-2 adrenergic agonists, is involved in inhibition of Na(+)-H+ exchange in renal proximal tubule cells.
    Bidet M; Poujeol P; Parini A
    J Hypertens Suppl; 1991 Dec; 9(6):S216-7. PubMed ID: 1687868
    [No Abstract]   [Full Text] [Related]  

  • 25. Identification, localization and functional analysis of imidazoline and alpha adrenergic receptors in canine prostate.
    Felsen D; Ernsberger P; Sutaria PM; Nejat RJ; Nguyen P; May M; Breslin DS; Marion DN; Vaughan ED
    J Pharmacol Exp Ther; 1994 Feb; 268(2):1063-71. PubMed ID: 7509387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Separation of alpha-adrenergic and imidazoline/guanidinium receptive sites (IGRS) activity in a series of imidazoline analogues of cirazoline.
    Brasili L; Pigini M; Marucci G; Quaglia W; Malmusi L; Lanier SM; Lanier B
    Bioorg Med Chem; 1995 Nov; 3(11):1503-9. PubMed ID: 8634830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue-specific localization of mitochondrial imidazoline-guanidinium receptive sites.
    Tesson F; Limon I; Parini A
    Eur J Pharmacol; 1992 Aug; 219(2):335-8. PubMed ID: 1425960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of guanidinium compounds and K+ channel modulators with imidazoline binding sites in rabbit kidney.
    Corpus VM; Bressie SM; Stillwell LI; Olins GM
    Eur J Pharmacol; 1994 Jan; 266(2):197-200. PubMed ID: 8157074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between alpha 2-adrenergic receptors and imidazoline/guanidinium receptive sites.
    Lanier SM; Raddatz R; Parini A
    Adv Pharmacol; 1998; 42():474-7. PubMed ID: 9327942
    [No Abstract]   [Full Text] [Related]  

  • 30. Subcellular distribution of imidazoline-guanidinium-receptive sites in human and rabbit liver. Major localization to the mitochondrial outer membrane.
    Tesson F; Prip-Buus C; Lemoine A; Pegorier JP; Parini A
    J Biol Chem; 1991 Jan; 266(1):155-60. PubMed ID: 1845963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. I(2)-imidazoline binding site affinity of a structurally different type of ligands.
    Dardonville C; Rozas I; Callado LF; Meana JJ
    Bioorg Med Chem; 2002 May; 10(5):1525-33. PubMed ID: 11886814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imidazoline receptors, subclassification, and drug-induced regulation.
    Hamilton CA
    Ann N Y Acad Sci; 1995 Jul; 763():57-65. PubMed ID: 7677375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The elusive family of imidazoline binding sites.
    Parini A; Moudanos CG; Pizzinat N; Lanier SM
    Trends Pharmacol Sci; 1996 Jan; 17(1):13-6. PubMed ID: 8789353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proceedings of the 3rd International Symposium on Imidazoline Receptors. Bonn, Germany, July 22-24, 1998.
    Ann N Y Acad Sci; 1999 Jun; 881():1-454. PubMed ID: 10447499
    [No Abstract]   [Full Text] [Related]  

  • 35. The metabolism of clonidine and related imidazoline derivatives in rat liver [proceedings].
    Baillie TA; Davies DL; Davies DS; Hughes H; Neill E
    Br J Pharmacol; 1978 Jun; 63(2):400P. PubMed ID: 667474
    [No Abstract]   [Full Text] [Related]  

  • 36. Keeping an eye on the I site: imidazoline-preferring receptors.
    Michel MC; Ernsberger P
    Trends Pharmacol Sci; 1992 Oct; 13(10):369-70. PubMed ID: 1413085
    [No Abstract]   [Full Text] [Related]  

  • 37. Are there multiple imidazoline binding sites?
    Michel MC; Insel PA
    Trends Pharmacol Sci; 1989 Sep; 10(9):342-4. PubMed ID: 2690423
    [No Abstract]   [Full Text] [Related]  

  • 38. [About the Influence of Pain and Itching Thresholds by 2-Phenylbenzylaminomethyl-Imidazoline (Antistine)].
    SPIER HW
    Zentralbl Haut Geschlechtskr Grenzgeb; 1949 Feb; 72(5):255. PubMed ID: 18200708
    [No Abstract]   [Full Text] [Related]  

  • 39. Romancing receptor research at Verona classification meeting.
    Bond RA; Girdlestone D
    Trends Pharmacol Sci; 1996 Mar; 17(3):85-9. PubMed ID: 8936341
    [No Abstract]   [Full Text] [Related]  

  • 40. [Imidazoline-guanidine site: a subtype of imidazoline receptors].
    Coupry I; Limon I; Tesson F; Lachaud V; Gargalidis-Moudanos C; Parini A
    Therapie; 1992 Nov; 47(6):519-24. PubMed ID: 1338740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.